Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Receptor, Angiotensin, Type 2 MeSH Descriptor Data 2025
An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.
Entry Version
RECEPT ANGIOTENSIN TYPE 2
Entry Term(s)
Angiotensin AT2 Receptor
Angiotensin II Type 2 Receptor
Angiotensin Type 2 Receptor
Receptor, Angiotensin II Type 2
Registry Numbers
0
Previous Indexing
Receptors, Angiotensin (1996-2003)
Public MeSH Note
2004; ANGIOTENSIN II TYPE 2 RECEPTOR (now RECEPTOR, ANGIOTENSIN, TYPE 2) was indexed under RECEPTORS, ANGIOTENSIN 1996-2003
History Note
2004; use RECEPTOR, ANGIOTENSIN, TYPE 2 (NM) 1996-2003
An angiotensin receptor subtype that is expressed at high levels in fetal tissues. Many effects of the angiotensin type 2 receptor such as VASODILATION and sodium loss are the opposite of that of the ANGIOTENSIN TYPE 1 RECEPTOR.